Application of Patient-Generated Health Data Among Older Adults With Cancer: Scoping Review

The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms...

Full description

Saved in:
Bibliographic Details
Published inJournal of medical Internet research Vol. 27; no. 5; p. e57379
Main Authors Kim, Yesol, Kim, Geonah, Cho, Hyeonmi, Kim, Yeonju, Choi, Mona
Format Journal Article
LanguageEnglish
Published Canada Journal of Medical Internet Research 04.02.2025
Gunther Eysenbach MD MPH, Associate Professor
JMIR Publications
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. Guided by Arksey and O'Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant's home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care. Open Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5.
AbstractList Background:The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms.Objective:This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD.Methods:Guided by Arksey and O’Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics.Results:Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant’s home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%).Conclusions:This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care.Trial Registration:Open Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5
The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. Guided by Arksey and O'Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant's home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care. Open Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5.
The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms.BACKGROUNDThe advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms.This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD.OBJECTIVEThis scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD.Guided by Arksey and O'Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics.METHODSGuided by Arksey and O'Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics.Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant's home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%).RESULTSOf the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant's home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%).This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care.CONCLUSIONSThis scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care.Open Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5.TRIAL REGISTRATIONOpen Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5.
Background The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. Objective This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. Methods Guided by Arksey and O’Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. Results Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant’s home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). Conclusions This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care. Trial Registration Open Science Framework Registry OSF.IO/FZRD5;
BackgroundThe advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. ObjectiveThis scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. MethodsGuided by Arksey and O’Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. ResultsOf the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant’s home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). ConclusionsThis scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care. Trial RegistrationOpen Science Framework Registry OSF.IO/FZRD5; https://doi.org/10.17605/OSF.IO/FZRD5
The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data (PGHD). In particular, PGHD may be promising for older adults with cancer who have increased survival rates and experience a variety of symptoms. This scoping review aimed to identify the characteristics of research on PGHD as applied to older adults with cancer and to assess the current use of PGHD. Guided by Arksey and O’Malley as well as the JBI (Joanna Briggs Institute) methodology for scoping reviews, 6 electronic databases were searched: PubMed, Embase, CINAHL, Cochrane Library, Scopus, and Web of Science. In addition, the reference lists of the selected studies were screened to identify gray literature. The researchers independently screened the literature according to the predefined eligibility criteria. Data from the selected studies were extracted, capturing study, participant, and PGHD characteristics. Of the 1090 identified studies, 88 were selected. The publication trend gradually increased, with a majority of studies published since 2017 (69/88, 78%). Almost half of the studies were conducted in North America (38/88, 43%), followed by Europe (30/88, 34%). The most common setting in which the studies were conducted was the participant’s home (69/88, 78%). The treatment status varied; the median sample size was 50 (IQR 33.8-84.0). The devices that were used to measure the PGHD were classified as research-grade wearable devices (57/113, 50.4%), consumer-grade wearable devices (28/113, 24.8%), or smartphones or tablet PCs for mobile apps (23/113, 20.4%). More than half of the studies measured physical activity (69/123, 56.1%), followed by patient-reported outcomes (23/123, 18.7%), vital signs (13/123, 10.6%), and sleep (12/123, 9.8%). The PGHD were mainly collected passively (63/88, 72%), and active collection methods were used from 2015 onward (20/88, 23%). In this review, the stages of PGHD use were classified as follows: (1) identification, monitoring, review, and analysis (88/88, 100%); (2) feedback and reporting (32/88, 39%); (3) motivation (30/88, 34%); and (4) education and coaching (19/88, 22%). This scoping review provides a comprehensive summary of the overall characteristics and use stages of PGHD in older adults with various types and stages of cancer. Future research should emphasize the use of PGHD, which interacts with patients to provide patient-centered care through patient engagement. By enhancing symptom monitoring, enabling timely interventions, and promoting patient involvement, PGHD have the potential to improve the well-being of older adults with cancer, contributing to better health management and quality of life. Therefore, our findings may provide valuable insights into PGHD that health care providers and researchers can use for geriatric cancer care.
Audience Academic
Author Kim, Yesol
Kim, Yeonju
Choi, Mona
Kim, Geonah
Cho, Hyeonmi
AuthorAffiliation 4 Mo-Im Kim Nursing Research Institute College of Nursing Yonsei University Seoul Republic of Korea
1 College of Nursing and Brain Korea 21 FOUR Project Yonsei University Seoul Republic of Korea
5 Research Institute of AI and Nursing Science College of Nursing Gachon University Incheon Republic of Korea
6 Yonsei Evidence Based Nursing Centre, A JBI Affiliated Group Seoul Republic of Korea
3 Severance Hospital Yonsei University Health System Seoul Republic of Korea
2 College of Nursing Gyeongsang National University Jinju Republic of Korea
AuthorAffiliation_xml – name: 6 Yonsei Evidence Based Nursing Centre, A JBI Affiliated Group Seoul Republic of Korea
– name: 3 Severance Hospital Yonsei University Health System Seoul Republic of Korea
– name: 1 College of Nursing and Brain Korea 21 FOUR Project Yonsei University Seoul Republic of Korea
– name: 2 College of Nursing Gyeongsang National University Jinju Republic of Korea
– name: 5 Research Institute of AI and Nursing Science College of Nursing Gachon University Incheon Republic of Korea
– name: 4 Mo-Im Kim Nursing Research Institute College of Nursing Yonsei University Seoul Republic of Korea
Author_xml – sequence: 1
  givenname: Yesol
  orcidid: 0000-0002-3540-1723
  surname: Kim
  fullname: Kim, Yesol
– sequence: 2
  givenname: Geonah
  orcidid: 0009-0008-5373-133X
  surname: Kim
  fullname: Kim, Geonah
– sequence: 3
  givenname: Hyeonmi
  orcidid: 0000-0001-7296-2581
  surname: Cho
  fullname: Cho, Hyeonmi
– sequence: 4
  givenname: Yeonju
  orcidid: 0009-0001-6797-6716
  surname: Kim
  fullname: Kim, Yeonju
– sequence: 5
  givenname: Mona
  orcidid: 0000-0003-4694-0359
  surname: Choi
  fullname: Choi, Mona
BackLink https://www.ncbi.nlm.nih.gov/pubmed/39903506$$D View this record in MEDLINE/PubMed
BookMark eNptkttu1DAQhiNURA_0FVAkhMRNig9xbHODVgu0lSoVcRAXXFgTZ7z1KrG3TlLE2-N2S-ki5AuPZj7_4xn9h8VeiAGL4piSE0Z180ZILvWT4oDWXFVKSbr3KN4vDsdxTQgjtabPin2uNeGCNAfFj8Vm03sLk4-hjK78lCMMU3WKARNM2JVnCP10Vb6HCcrFEMOqvOw7TOWim_tpLL_7XFxCsJjell9s3PhMfMYbjz-fF08d9CMe399HxbePH74uz6qLy9Pz5eKisrXSU1VbRGhZrSQ2xCnrrAIpaFszELJjUgAQrRwXmgmrrOqscFwB72rnXGsZPyrOt7pdhLXZJD9A-mUieHOXiGllIE3e9mia2gqrGyWolDV3rQLVuJyTUqDjQLLWu63WZm4H7GzeRYJ-R3S3EvyVWcUbQ6nijdA0K7y-V0jxesZxMoMfLfY9BIzzaDht8uqpIDqjL_9B13FOIe_KcMYYz_9k8i-1gjyBDy7mxvZW1CwUa6hiNRGZOvkPlU-Hg7fZK87n_M6DF48nfRjxjzcy8GoL2BTHMaF7QCgxt54zd57jvwE3U8UM
Cites_doi 10.2196/mhealth.6829
10.2196/jmir.7838
10.3322/caac.21731
10.1007/s00520-018-4493-6
10.1016/j.lungcan.2013.11.014
10.1177/1534735416684016
10.11124/JBIES-20-00167
10.1097/SPC.0000000000000439
10.2196/humanfactors.5919
10.1249/MSS.0000000000000241
10.1111/ecc.13497
10.1111/j.1365-2354.2010.01205.x
10.1186/s12955-020-01480-3
10.1371/journal.pone.0246101
10.2196/35694
10.1177/1932296817750401
10.5993/AJHB.44.1.10
10.2196/18819
10.1186/s12966-018-0734-9
10.1016/j.cppeds.2021.101103
10.1007/s00520-014-2177-4
10.1007/s10552-009-9460-6
10.1002/cncr.29385
10.2196/cancer.7599
10.1001/jamanetworkopen.2021.22998
10.3390/cancers13235925
10.1007/s00520-019-04998-5
10.3390/cancers12071938
10.1080/1364557032000119616
10.1371/journal.pone.0240967
10.3109/07420528.2013.864301
10.1002/cncr.31745
10.1007/s11764-012-0239-5
10.1097/NCC.0000000000000647
10.1177/1534735419894061
10.1245/s10434-020-08705-1
10.1016/j.eururo.2018.12.040
10.1002/cncr.28951
10.1249/MSS.0000000000000727
10.2196/14537
10.1016/j.semradonc.2019.05.008
10.1007/s00520-017-3721-9
10.2196/19180
10.2196/34384
10.1016/j.jpainsymman.2006.03.014
10.1002/cncr.31024
10.2196/20738
10.1200/EDBK_390678
10.1111/ijn.13019
10.2196/27349
10.1016/j.jgo.2022.06.004
10.1080/0284186X.2021.1896032
10.1111/jgs.17369
10.1007/s00520-019-05230-0
10.1080/07420528.2017.1293678
10.1016/j.ejon.2015.02.013
10.7748/phc.2017.e1225
10.1002/jso.26413
10.2196/17855
10.1007/s11764-022-01260-6
10.2196/29788
10.1016/j.clon.2021.04.008
10.1002/cam4.4382
10.1016/j.jgo.2019.01.010
10.2196/25791
10.14423/SMJ.0000000000000956
10.2196/mhealth.5426
10.1111/ijn.12658
10.1111/jgs.14589
10.1007/s00066-019-01548-0
10.1016/j.ejso.2019.04.013
10.1123/jmpb.2021-0046
10.1158/1078-0432.CCR-07-1147
10.2196/27975
10.2196/36284
10.1016/j.outlook.2019.04.005
10.3109/13685538.2011.582528
10.1200/JOP.2015.003715
10.4258/hir.2021.27.4.267
10.2307/249008
10.1097/NCC.0000000000000128
10.1038/s41430-019-0418-9
10.1016/j.pmedr.2016.06.022
10.1007/s10552-016-0787-5
10.1080/07420528.2017.1391278
10.3390/cancers14112742
10.1177/1534735414542484
10.1245/s10434-021-09707-3
10.1016/j.ijrobp.2017.02.002
10.2196/47380
10.1002/jso.25789
10.2196/29027
10.7326/M18-0850
10.3322/caac.21608
10.1016/S1470-2045(18)30348-6
10.1186/s12885-022-09629-7
10.1016/j.jgo.2017.09.008
10.1016/j.clml.2020.06.024
10.21037/jtd.2020.01.23
10.1136/bmjopen-2020-046393
10.2196/13320
10.1177/1049909113510963
10.1007/s12529-016-9575-6
10.1016/j.ejso.2020.06.012
10.1017/S1478951517000815
10.1001/jamasurg.2019.4702
10.1016/j.jpainsymman.2019.08.016
10.1007/s00520-009-0776-2
10.1186/s12966-018-0686-0
10.1097/CIN.0000000000001109
10.1016/j.lungcan.2018.03.010
10.1080/0284186X.2019.1633473
10.1016/j.urolonc.2020.11.035
10.1177/1049909116649948
10.1186/s12885-018-5189-5
10.1136/bmjopen-2018-025114
10.1097/JU.0000000000000050
10.1186/s41687-020-00255-0
10.1186/s12885-021-08084-0
10.1017/S1478951518001074
10.1139/H07-074
10.1007/978-3-031-27173-1_15
10.2196/19238
10.1007/s00520-017-3625-8
10.1007/s11764-016-0553-4
10.1007/s11764-013-0293-7
10.1016/j.eururo.2013.09.041
10.1093/jamia/ocv184
10.1016/S1470-2045(16)30573-3
ContentType Journal Article
Copyright Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025.
COPYRIGHT 2025 Journal of Medical Internet Research
2025. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025. 2025
Copyright_xml – notice: Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025.
– notice: COPYRIGHT 2025 Journal of Medical Internet Research
– notice: 2025. This work is licensed under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025. 2025
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7QJ
7RV
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
ALSLI
AZQEC
BENPR
CCPQU
CNYFK
DWQXO
E3H
F2A
FYUFA
GHDGH
K9.
KB0
M0S
M1O
NAPCQ
PHGZM
PHGZT
PIMPY
PKEHL
PPXIY
PQEST
PQQKQ
PQUKI
PRINS
PRQQA
7X8
5PM
DOA
DOI 10.2196/57379
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Applied Social Sciences Index & Abstracts (ASSIA)
Nursing & Allied Health Database
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
ProQuest Hospital Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
Social Science Premium Collection
ProQuest Central Essentials
ProQuest Central
ProQuest One
Library & Information Science Collection
ProQuest Central Korea
Library & Information Sciences Abstracts (LISA)
Library & Information Science Abstracts (LISA)
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Nursing & Allied Health Database (Alumni Edition)
ProQuest Health & Medical Collection
Library Science Database
Nursing & Allied Health Premium
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest One Social Sciences
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
Library and Information Science Abstracts (LISA)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest One Health & Nursing
Applied Social Sciences Index and Abstracts (ASSIA)
ProQuest Central China
ProQuest Central
ProQuest Library Science
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
Library & Information Science Collection
ProQuest Central (New)
Social Science Premium Collection
ProQuest One Social Sciences
ProQuest One Academic Eastern Edition
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Hospital Collection (Alumni)
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
ProQuest One Academic UKI Edition
ProQuest Nursing & Allied Health Source (Alumni)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database
MEDLINE
MEDLINE - Academic



Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 4
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Library & Information Science
EISSN 1438-8871
ExternalDocumentID oai_doaj_org_article_64c5c968517743fb8a86f4c5775ef3a0
PMC11836591
A826182405
39903506
10_2196_57379
Genre Journal Article
Scoping Review
GeographicLocations South Korea
United States--US
GeographicLocations_xml – name: South Korea
– name: United States--US
GroupedDBID ---
.4I
.DC
29L
2WC
36B
53G
5GY
5VS
77K
7RV
7X7
8FI
8FJ
AAFWJ
AAKPC
AAWTL
AAYXX
ABDBF
ABIVO
ABUWG
ACGFO
ADBBV
AEGXH
AENEX
AFKRA
AFPKN
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
ALSLI
AOIJS
BAWUL
BCNDV
BENPR
CCPQU
CITATION
CNYFK
CS3
DIK
DU5
DWQXO
E3Z
EAP
EBD
EBS
EJD
ELW
EMB
EMOBN
ESX
F5P
FRP
FYUFA
GROUPED_DOAJ
GX1
HMCUK
HYE
IAO
ICO
IEA
IHR
INH
ISN
ITC
KQ8
M1O
M48
NAPCQ
OK1
OVT
P2P
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
RNS
RPM
SJN
SV3
TR2
UKHRP
XSB
ACUHS
CGR
CUY
CVF
ECM
EIF
NPM
PPXIY
PRQQA
PMFND
3V.
7QJ
7XB
8FK
AZQEC
E3H
F2A
K9.
PKEHL
PQEST
PQUKI
PRINS
PUEGO
7X8
5PM
ID FETCH-LOGICAL-c489t-4ceeab2487e60f8cfc8a751b42a57d275aa098f35925c8c8dc5f38a3d4fffbc23
IEDL.DBID 7X7
ISSN 1438-8871
1439-4456
IngestDate Wed Aug 27 01:29:04 EDT 2025
Thu Aug 21 18:28:41 EDT 2025
Fri Jul 11 07:02:54 EDT 2025
Sat Aug 23 13:49:53 EDT 2025
Tue Jun 17 22:00:07 EDT 2025
Tue Jun 10 20:57:47 EDT 2025
Mon Jul 21 06:01:36 EDT 2025
Tue Jul 01 02:06:21 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords patient-reported outcomes
wearable devices
patient-centered care
older adults
cancer
patient-generated health data
scoping review
Language English
License Yesol Kim, Geonah Kim, Hyeonmi Cho, Yeonju Kim, Mona Choi. Originally published in the Journal of Medical Internet Research (https://www.jmir.org), 04.02.2025.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in the Journal of Medical Internet Research (ISSN 1438-8871), is properly cited. The complete bibliographic information, a link to the original publication on https://www.jmir.org/, as well as this copyright and license information must be included.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c489t-4ceeab2487e60f8cfc8a751b42a57d275aa098f35925c8c8dc5f38a3d4fffbc23
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
ObjectType-Review-3
content type line 23
ORCID 0009-0008-5373-133X
0009-0001-6797-6716
0000-0003-4694-0359
0000-0001-7296-2581
0000-0002-3540-1723
OpenAccessLink https://www.proquest.com/docview/3222368527?pq-origsite=%requestingapplication%
PMID 39903506
PQID 3222368527
PQPubID 2033121
ParticipantIDs doaj_primary_oai_doaj_org_article_64c5c968517743fb8a86f4c5775ef3a0
pubmedcentral_primary_oai_pubmedcentral_nih_gov_11836591
proquest_miscellaneous_3163501509
proquest_journals_3222368527
gale_infotracmisc_A826182405
gale_infotracacademiconefile_A826182405
pubmed_primary_39903506
crossref_primary_10_2196_57379
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20250204
PublicationDateYYYYMMDD 2025-02-04
PublicationDate_xml – month: 2
  year: 2025
  text: 20250204
  day: 4
PublicationDecade 2020
PublicationPlace Canada
PublicationPlace_xml – name: Canada
– name: Toronto
– name: Toronto, Canada
PublicationTitle Journal of medical Internet research
PublicationTitleAlternate J Med Internet Res
PublicationYear 2025
Publisher Journal of Medical Internet Research
Gunther Eysenbach MD MPH, Associate Professor
JMIR Publications
Publisher_xml – name: Journal of Medical Internet Research
– name: Gunther Eysenbach MD MPH, Associate Professor
– name: JMIR Publications
References ref57
ref56
ref59
ref58
ref53
ref52
ref55
ref54
ref51
ref50
ref46
ref45
ref48
ref47
ref42
ref41
Morgan, R (ref120) 2023
ref44
ref43
ref49
ref8
ref7
ref9
ref4
ref3
ref6
ref5
ref100
ref101
ref40
ref35
ref34
ref37
ref36
ref31
ref30
ref33
ref32
ref39
ref38
ref24
ref23
ref26
ref25
ref20
ref22
ref21
ref28
ref27
ref29
ref13
ref12
ref15
ref128
ref14
ref129
ref97
ref126
ref96
ref127
ref11
ref99
ref124
ref10
ref98
ref125
ref17
ref16
ref19
ref18
ref93
ref92
ref95
ref94
ref130
ref91
ref90
ref89
ref86
ref85
ref88
ref87
ref82
ref81
ref84
ref83
ref80
ref79
ref108
ref78
ref109
ref106
ref107
ref75
ref104
ref74
ref105
ref77
ref102
ref76
ref103
ref2
ref1
ref71
ref111
ref70
ref112
ref73
ref72
ref110
ref68
ref119
ref67
ref117
ref69
ref118
ref64
ref115
ref63
ref116
ref66
ref113
ref65
ref114
ref60
ref122
ref123
ref62
ref61
ref121
References_xml – ident: ref42
  doi: 10.2196/mhealth.6829
– ident: ref38
  doi: 10.2196/jmir.7838
– ident: ref1
  doi: 10.3322/caac.21731
– ident: ref65
  doi: 10.1007/s00520-018-4493-6
– ident: ref27
  doi: 10.1016/j.lungcan.2013.11.014
– ident: ref46
  doi: 10.1177/1534735416684016
– ident: ref14
  doi: 10.11124/JBIES-20-00167
– ident: ref5
  doi: 10.1097/SPC.0000000000000439
– ident: ref106
  doi: 10.2196/humanfactors.5919
– ident: ref116
  doi: 10.1249/MSS.0000000000000241
– ident: ref96
  doi: 10.1111/ecc.13497
– ident: ref9
– ident: ref22
  doi: 10.1111/j.1365-2354.2010.01205.x
– ident: ref83
  doi: 10.1186/s12955-020-01480-3
– ident: ref95
  doi: 10.1371/journal.pone.0246101
– ident: ref101
  doi: 10.2196/35694
– ident: ref112
  doi: 10.1177/1932296817750401
– ident: ref82
  doi: 10.5993/AJHB.44.1.10
– ident: ref87
  doi: 10.2196/18819
– ident: ref50
  doi: 10.1186/s12966-018-0734-9
– ident: ref107
  doi: 10.1016/j.cppeds.2021.101103
– ident: ref24
  doi: 10.1007/s00520-014-2177-4
– ident: ref19
  doi: 10.1007/s10552-009-9460-6
– ident: ref31
  doi: 10.1002/cncr.29385
– ident: ref40
  doi: 10.2196/cancer.7599
– ident: ref92
  doi: 10.1001/jamanetworkopen.2021.22998
– ident: ref88
  doi: 10.3390/cancers13235925
– ident: ref73
  doi: 10.1007/s00520-019-04998-5
– ident: ref78
  doi: 10.3390/cancers12071938
– ident: ref13
  doi: 10.1080/1364557032000119616
– ident: ref72
  doi: 10.1371/journal.pone.0240967
– ident: ref28
  doi: 10.3109/07420528.2013.864301
– ident: ref55
  doi: 10.1002/cncr.31745
– ident: ref6
  doi: 10.1007/s11764-012-0239-5
– ident: ref76
  doi: 10.1097/NCC.0000000000000647
– ident: ref64
  doi: 10.1177/1534735419894061
– ident: ref90
  doi: 10.1245/s10434-020-08705-1
– ident: ref60
  doi: 10.1016/j.eururo.2018.12.040
– ident: ref108
  doi: 10.1002/cncr.28951
– ident: ref113
  doi: 10.1249/MSS.0000000000000727
– ident: ref128
  doi: 10.2196/14537
– ident: ref105
  doi: 10.1016/j.semradonc.2019.05.008
– ident: ref39
  doi: 10.1007/s00520-017-3721-9
– ident: ref79
  doi: 10.2196/19180
– ident: ref111
  doi: 10.2196/34384
– ident: ref17
  doi: 10.1016/j.jpainsymman.2006.03.014
– ident: ref51
  doi: 10.1002/cncr.31024
– ident: ref110
  doi: 10.2196/20738
– ident: ref119
  doi: 10.1200/EDBK_390678
– ident: ref102
  doi: 10.1111/ijn.13019
– ident: ref104
  doi: 10.2196/27349
– ident: ref125
  doi: 10.1016/j.jgo.2022.06.004
– ident: ref93
  doi: 10.1080/0284186X.2021.1896032
– ident: ref4
  doi: 10.1111/jgs.17369
– ident: ref77
  doi: 10.1007/s00520-019-05230-0
– ident: ref37
  doi: 10.1080/07420528.2017.1293678
– ident: ref32
  doi: 10.1016/j.ejon.2015.02.013
– ident: ref45
  doi: 10.7748/phc.2017.e1225
– ident: ref94
  doi: 10.1002/jso.26413
– ident: ref71
  doi: 10.2196/17855
– ident: ref126
  doi: 10.1007/s11764-022-01260-6
– ident: ref122
  doi: 10.2196/29788
– ident: ref85
  doi: 10.1016/j.clon.2021.04.008
– ident: ref99
  doi: 10.1002/cam4.4382
– ident: ref67
  doi: 10.1016/j.jgo.2019.01.010
– ident: ref97
  doi: 10.2196/25791
– ident: ref62
  doi: 10.14423/SMJ.0000000000000956
– ident: ref33
  doi: 10.2196/mhealth.5426
– ident: ref53
  doi: 10.1111/ijn.12658
– ident: ref115
  doi: 10.1111/jgs.14589
– ident: ref69
  doi: 10.1007/s00066-019-01548-0
– ident: ref66
  doi: 10.1016/j.ejso.2019.04.013
– ident: ref114
  doi: 10.1123/jmpb.2021-0046
– ident: ref18
  doi: 10.1158/1078-0432.CCR-07-1147
– ident: ref91
  doi: 10.2196/27975
– ident: ref124
  doi: 10.2196/36284
– ident: ref8
  doi: 10.1016/j.outlook.2019.04.005
– ident: ref21
  doi: 10.3109/13685538.2011.582528
– ident: ref10
  doi: 10.1200/JOP.2015.003715
– ident: ref127
  doi: 10.4258/hir.2021.27.4.267
– ident: ref130
  doi: 10.2307/249008
– ident: ref30
  doi: 10.1097/NCC.0000000000000128
– ident: ref59
  doi: 10.1038/s41430-019-0418-9
– ident: ref35
  doi: 10.1016/j.pmedr.2016.06.022
– ident: ref34
  doi: 10.1007/s10552-016-0787-5
– ident: ref48
  doi: 10.1080/07420528.2017.1391278
– ident: ref103
  doi: 10.3390/cancers14112742
– ident: ref26
  doi: 10.1177/1534735414542484
– ident: ref89
  doi: 10.1245/s10434-021-09707-3
– ident: ref36
  doi: 10.1016/j.ijrobp.2017.02.002
– ident: ref123
  doi: 10.2196/47380
– ident: ref68
  doi: 10.1002/jso.25789
– ident: ref12
  doi: 10.2196/29027
– ident: ref15
  doi: 10.7326/M18-0850
– ident: ref118
  doi: 10.3322/caac.21608
– ident: ref3
  doi: 10.1016/S1470-2045(18)30348-6
– ident: ref100
  doi: 10.1186/s12885-022-09629-7
– ident: ref52
  doi: 10.1016/j.jgo.2017.09.008
– ident: ref80
  doi: 10.1016/j.clml.2020.06.024
– ident: ref75
  doi: 10.21037/jtd.2020.01.23
– ident: ref11
  doi: 10.1136/bmjopen-2020-046393
– ident: ref16
  doi: 10.2196/13320
– ident: ref29
  doi: 10.1177/1049909113510963
– ident: ref41
  doi: 10.1007/s12529-016-9575-6
– ident: ref74
  doi: 10.1016/j.ejso.2020.06.012
– ident: ref47
  doi: 10.1017/S1478951517000815
– ident: ref81
  doi: 10.1001/jamasurg.2019.4702
– ident: ref121
  doi: 10.1016/j.jpainsymman.2019.08.016
– ident: ref20
  doi: 10.1007/s00520-009-0776-2
– ident: ref54
  doi: 10.1186/s12966-018-0686-0
– ident: ref129
  doi: 10.1097/CIN.0000000000001109
– ident: ref49
  doi: 10.1016/j.lungcan.2018.03.010
– ident: ref58
  doi: 10.1080/0284186X.2019.1633473
– ident: ref98
  doi: 10.1016/j.urolonc.2020.11.035
– ident: ref44
  doi: 10.1177/1049909116649948
– ident: ref56
  doi: 10.1186/s12885-018-5189-5
– ident: ref61
  doi: 10.1136/bmjopen-2018-025114
– ident: ref63
  doi: 10.1097/JU.0000000000000050
– ident: ref84
  doi: 10.1186/s41687-020-00255-0
– ident: ref86
  doi: 10.1186/s12885-021-08084-0
– ident: ref57
  doi: 10.1017/S1478951518001074
– ident: ref117
  doi: 10.1139/H07-074
– start-page: 291
  year: 2023
  ident: ref120
  publication-title: Clinical Research Informatics
  doi: 10.1007/978-3-031-27173-1_15
– ident: ref70
  doi: 10.2196/19238
– ident: ref43
  doi: 10.1007/s00520-017-3625-8
– ident: ref2
  doi: 10.1007/s11764-016-0553-4
– ident: ref23
  doi: 10.1007/s11764-013-0293-7
– ident: ref25
  doi: 10.1016/j.eururo.2013.09.041
– ident: ref7
  doi: 10.1093/jamia/ocv184
– ident: ref109
  doi: 10.1016/S1470-2045(16)30573-3
SSID ssj0020491
Score 2.4311209
SecondaryResourceType review_article
Snippet The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated health data...
Background The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated...
Background:The advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated...
BackgroundThe advancement of information and communication technologies has spurred a growing interest in and increased applications of patient-generated...
SourceID doaj
pubmedcentral
proquest
gale
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage e57379
SubjectTerms Aged
Cancer
Cardiovascular disease
Care and treatment
Chronic illnesses
Citation management software
Clinical outcomes
Coaching
Communications technology
Data collection
Diabetes
Disease management
Health aspects
Health information
Humans
Information technology
Medical equipment
Medical personnel
Medical records
Medical research
Medical Subject Headings-MeSH
Motivation
Multimedia
Neoplasms
Older people
Outdoor air quality
Patient compliance
Patient Generated Health Data
Patient participation
Patient-centered care
Patients
Physical activity
Physiology
Quality of life
Review
Wearable computers
SummonAdditionalLinks – databaseName: DOAJ Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NT9wwEB0hDqgSQi0tJS0gI1XtKWrWsR2nt5QPISRoD0VF6sGyHVvlkq1g-f-dib3bjXrgwjXOamPPTGZeZuYNwAfK-CM27kvZh7oU3MeyrXpeWnQdvWqssI6-d1xdq4sbcXkrb9dGfVFNWKIHTgf3WQkvfatohDw6u-i01SritaaRIdZ2ROvo85ZgKkMtjHtnW7BNhc6oYoj6a6rVWvM8I0H__6_hNT80rZFcczrnL2EnR4usS0_5CjbCsAuHudeAfWS5mYgOl2Ur3YWtq5wvfw2_un_5aTaP7HtiUS0T2TQGmyy1IbFTu7Cso8FD7BvN7WYd8XI8sJ93uHhCmnH_Bf9h7K5iKZ_wBm7Oz36cXJR5nELphW4XpUB_aB1HhBJUFbWPXttGzpzgVjY9b6S1VatjLVsuvfa69zLW2ta9iDE6z-s92BzmQ9gH1gQnKfSzUisRgnP4xteuEi5WVlk5K-BoedTmT2LNMIg2SBZmlEUBX0kAq0UiuR4voOhNFr15SvQFfCLxGTJFlJG3uaMAn5FIrUyH0AnhE4akBRxM7kQT8tPlpQKYbMIPhlJQxM7PmwKOV8v0SypLG8L8Ee_BaFbSNyPc0NukL6stYeRHWVtVgJ5o0mTP05Xh7vdI8I2gr1aynb17jlN6Dy84zSymSnNxAJuL-8dwiIHUwh2NNvMXUuYbmg
  priority: 102
  providerName: Directory of Open Access Journals
Title Application of Patient-Generated Health Data Among Older Adults With Cancer: Scoping Review
URI https://www.ncbi.nlm.nih.gov/pubmed/39903506
https://www.proquest.com/docview/3222368527
https://www.proquest.com/docview/3163501509
https://pubmed.ncbi.nlm.nih.gov/PMC11836591
https://doaj.org/article/64c5c968517743fb8a86f4c5775ef3a0
Volume 27
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3da9RAEB-0hSJI0ao1tT1WEH0KJpvdZOOLpLWlCNcWsXjgQ9jd7Gpfknp3_f-dSfY-guDLPWQSLpuZ2Z3P3wC8o4w_-sZNLBuXxYJbH5dJw2ONR0eTF1poQ_GO6VV-eSu-zuQsBNwWoaxytSf2G3XTWYqRf6SMAIGl8-Lz_Z-YpkZRdjWM0HgMuwRdRiVdxWzjcKH1m-7BUyp3RkFD3z-jiq2t86eH6f93M946jcaVkltHz8Uz2A82I6sGJj-HR649gJPQccDes9BSRJ-YBV09gL1pyJq_gJ_VJkvNOs9uBizVeICcRpOTDc1I7ItealbR-CF2TdO7WUXoHAv24w6JZyQf80_4D32PFRuyCi_h9uL8-9llHIYqxFaochkLPBW14einuDzxynqrdCFTI7iWRcMLqXVSKp_JkkurrGqs9JnSWSO898by7BXstF3rXgMrnJFkAGqpcuGcMbjvK5MI4xOda5lGMFl96vp-wM6o0ecgXtQ9LyI4JQasiQR13V_o5r_qoDl1Lqy0JXI-RUs180ZplXu8VhTS-UwnEXwg9tWkkMgjq0NfAb4jQVvVFTpQ6EShYRrB8ehOVCQ7Jq8EoA6KvKg3YhfB2zWZnqTitNZ1D3gP2rSSIke4oMNBXtZLQvuPcrd5BGokSaM1jynt3e8e5htdvyyXZXr0__d6A084zSSmSnJxDDvL-YM7QUNpaSa9Nkxg9_T86ubbpA834O80vf4L2dYXDg
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3ra9RAEB_KFaogovUVbesKPj6F5rGbbASR9MXV9s4iLS34Ie5udrVfknp3Rfyn_BudSXLXC4Lf-jWTkGxmduY3Oy-A1xTxR9-49EVpY59HxvlZUEa-QtNRJqniStN5x2icDM_4pwtxsQJ_5rUwlFY514mNoi5rQ2fk2xQRoGbpUfrx6qdPU6MoujofodGKxZH9_QtdtumHwz3k75soOtg_3R363VQB33CZzXyOZkHpCIG6TQInjTNSpSLUPFIiLaNUKBVk0sUii4SRRpZGuFiquOTOOW2o0QGq_FUeoyszgNWd_fHJl4WLh3g7XIN7lGCNor0t0phyxJYsXjMY4F_1v2T_-rmZS8bu4AHc71Aqy1uxeggrtlqHza7Ggb1lXRETMZV12mEd1kZdnP4RfM1v4uKsduyk7d7qt02uEeSytvyJ7amZYjkNPGKfaV44y6kfyJSdXyJxlyRy8h7f0FR1sTaO8RjObuWHP4FBVVf2GbDUakGQUwmZcGu1RksjdcC1C1SiROjB1vxXF1dtt44CvRziRdHwwoMdYsCCSM21mwv15HvR7dUi4UaYDGUtRGwcOy2VTBxeS1NhXawCD94R-wpSAcgjo7pKBvxGaqZV5OiyoduGUNiDjd6duHVNnzwXgKJTHdPiRtA9eLUg05OUDlfZ-hrvQRQt6KwKF_S0lZfFkhBxUrQ48UD2JKm35j6luvzRNBZHZzNORBY-__93vYQ7w9PRcXF8OD56AXcjmohMeex8AwazybXdRJg201vd3mDw7ba3419RY1Om
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1ba9RAFD6UCosgovWW2tYRvDyF5jKTTASR2HVpra19sLjgQ5yZzGhfknZ3i_jX_HWek8vuBsG3vmYSksm5fWfODeAFRfzRNy59UdrY55FxfhaUka_QdJRJqrjSdN5xcpocnvOPUzHdgD99LQylVfY6sVHUZW3ojHyfIgLULB1dddelRZyNJ-8ur3yaIEWR1n6cRssix_b3L3Tf5m-Pxkjrl1E0-fDl4NDvJgz4hsts4XM0EUpHCNptEjhpnJEqFaHmkRJpGaVCqSCTLhZZJIw0sjTCxVLFJXfOaUNND1D930pjEZKMpdOVs4fIOxzBHUq1RibfF2lM2WJrtq8ZEfCvIVizhMMszTWzN7kHdzu8yvKWwe7Dhq22YLerdmCvWFfORORlnZ7YgtFJF7F_AN_yVYSc1Y6dtX1c_bbdNcJd1hZCsbFaKJbT6CP2mSaHs5w6g8zZ1wtcPCDenL3BNzT1XayNaDyE8xv53Y9gs6or-wRYarUg8KmETLi1WqPNkTrg2gUqUSL0YK__1cVl27ejQH-HaFE0tPDgPRFguUhttpsL9exH0UltkXAjTIZcFyJKjp2WSiYOr6WpsC5WgQeviXwFKQOkkVFdTQN-I7XVKnJ03tCBQ1Dswc7gThRiM1zuGaDolMi8WLG8B8-Xy_QkJcZVtr7GexBPCzq1wg09bvlluSXEnhQ3TjyQA04a7Hm4Ul38bFqMo9sZJyILt___Xc9ghEJYfDo6PX4KtyMajUwJ7XwHNheza7uLeG2h9xrBYPD9piXxLyqDVnY
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Application+of+Patient-Generated+Health+Data+Among+Older+Adults+With+Cancer%3A+Scoping+Review&rft.jtitle=Journal+of+medical+Internet+research&rft.au=Kim%2C+Yesol&rft.au=Kim%2C+Geonah&rft.au=Cho%2C+Hyeonmi&rft.au=Kim%2C+Yeonju&rft.date=2025-02-04&rft.pub=Journal+of+Medical+Internet+Research&rft.issn=1439-4456&rft.volume=27&rft.issue=5&rft_id=info:doi/10.2196%2F57379&rft.externalDocID=A826182405
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1438-8871&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1438-8871&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1438-8871&client=summon